The Staphylococcus aureus Transcriptome during Cystic Fibrosis Lung Infection
Although bacteria have been studied in infection for over 100 years, the majority of these studies have utilized laboratory and animal models that often have unknown relevance to the human infections they are meant to represent. A primary challenge has been to assess bacterial physiology in the huma...
Main Authors: | Carolyn B. Ibberson, Marvin Whiteley |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2019-11-01
|
Series: | mBio |
Subjects: | |
Online Access: | https://doi.org/10.1128/mBio.02774-19 |
Similar Items
-
<i>Staphylococcus aureus</i> Pathogenicity in Cystic Fibrosis Patients—Results from an Observational Prospective Multicenter Study Concerning Virulence Genes, Phylogeny, and Gene Plasticity
by: Jonas Lange, et al.
Published: (2020-04-01) -
Antimicrobial activity of dalbavancin and comparators against Staphylococcus aureus causing pneumonia in patients with and without cystic fibrosis
by: Helio S. Sader, et al.
Published: (2021-06-01) -
Antimicrobial Treatment of Staphylococcus aureus in Patients With Cystic Fibrosis
by: Susanna Esposito, et al.
Published: (2019-08-01) -
Lack of Sphingosine Causes Susceptibility to Pulmonary Staphylococcus Aureus Infections in Cystic Fibrosis
by: Shaghayegh Tavakoli Tabazavareh, et al.
Published: (2016-05-01) -
Transcriptome Profiling and Molecular Therapeutic Advances in Cystic Fibrosis: Recent Insights
by: Justin E. Ideozu, et al.
Published: (2019-02-01)